We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$532M
AUM Growth
+$46.2M
Cap. Flow
+$19.9M
Cap. Flow %
3.75%
Top 10 Hldgs %
55.23%
Holding
380
New
40
Increased
44
Reduced
45
Closed
14

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.91%
2 Real Estate 1.47%
3 Technology 1.42%
4 Industrials 0.57%
5 Healthcare 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
151
Micron Technology
MU
$996B
$59K 0.01%
+634
New +$49.5K
CLF icon
152
Cleveland-Cliffs
CLF
$6.98B
$56K 0.01%
2,558
BR icon
153
Broadridge
BR
$18.8B
$54K 0.01%
295
STLD icon
154
Steel Dynamics
STLD
$37.5B
$54K 0.01%
868
+4
+0.5% +$250
VIOO icon
155
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.22B
$53K 0.01%
500
MUI
156
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$53K 0.01%
3,478
CE icon
157
Celanese
CE
$4.82B
$52K 0.01%
310
DOW icon
158
Dow Inc
DOW
$21.9B
$52K 0.01%
916
ETN icon
159
Eaton
ETN
$174B
$52K 0.01%
300
ESGV icon
160
Vanguard ESG US Stock ETF
ESGV
$13.5B
$51K 0.01%
582
TSM icon
161
TSMC
TSM
$2.17T
$51K 0.01%
420
VEEV icon
162
Veeva Systems
VEEV
$35.4B
$51K 0.01%
201
V icon
163
Visa
V
$692B
$49K 0.01%
224
TMO icon
164
Thermo Fisher Scientific
TMO
$214B
$47K 0.01%
71
BURL icon
165
Burlington
BURL
$23.4B
$42K 0.01%
143
PAYC icon
166
Paycom
PAYC
$10.1B
$42K 0.01%
102
CVX icon
167
Chevron
CVX
$371B
$41K 0.01%
352
+74
+27% +$8.41K
VHT icon
168
Vanguard Health Care ETF
VHT
$18.4B
$41K 0.01%
155
CTXS
169
DELISTED
Citrix Systems Inc
CTXS
$41K 0.01%
435
NVS icon
170
Novartis
NVS
$293B
$39K 0.01%
441
GSK icon
171
GSK
GSK
$104B
$38K 0.01%
686
MSA icon
172
Mine Safety
MSA
$7.48B
$38K 0.01%
250
DBEF icon
173
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.33B
$37K 0.01%
930
MCHP icon
174
Microchip Technology
MCHP
$40.4B
$36K 0.01%
408
SLB icon
175
SLB Ltd
SLB
$76.5B
$36K 0.01%
1,200

Similar funds

Roble Belko & Company's Q4 2021 Portfolio in Review

As of Q4 2021, Roble Belko & Company held 380 positions worth $532M, up 9.5% from $486M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Roble Belko & Company deployed $19.9M of net new capital in Q4 2021, opening 40 new positions and adding to 44 existing holdings. Its largest new stake was KKR Real Estate Finance Trust: 177,914 shares worth $3.71M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.8% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $3M trimmed.

  • Roble Belko & Company's largest Q4 2021 buy was KKR Real Estate Finance Trust: 177,914 shares worth $3.71M.
  • Roble Belko & Company added most to Vanguard FTSE All-World ex-US ETF in Q4 2021, an estimated $6.18M increase.
  • Roble Belko & Company's biggest Q4 2021 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $3M.
  • Roble Belko & Company fully exited iShares iBonds Dec 2021 Term Corporate ETF in Q4 2021, selling an estimated $250K.
  • Roble Belko & Company's ten largest holdings make up 55% of its $532M portfolio in Q4 2021.
  • Roble Belko & Company opened 40 new positions and closed 14 in Q4 2021.
  • Roble Belko & Company's portfolio value rose 9.5% quarter-over-quarter to $532M.

Based on Roble Belko & Company's 13F filing for Q4 2021, filed 7 Feb 2022.